Russell Investments Group
ETNB

Russell Investments Group’s 89bio ETNB Stock Holding History

Russell Investments Group’s Portfolio ETNB Stock Details ETNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10,338
Closed -$152K – 4202
2025
Q3 		$152K Buy
+10,338
New +$105K ﹤0.01% 2893
2025
Q1 		– Sell
-25,241
Closed -$197K – 3823
2024
Q4 		$197K Sell
25,241
-18,172
-42% -$150K ﹤0.01% 2541
2024
Q3 		$321K Buy
43,413
+42,620
+5,375% +$358K ﹤0.01% 2389
2024
Q2 		$6.35K Buy
+793
New +$7.08K ﹤0.01% 3169
2023
Q4 		– Sell
-14
Closed -$216 – 3233
2023
Q3 		$216 Sell
14
-5,086
-100% -$85.4K ﹤0.01% 3488
2023
Q2 		$96.6K Buy
+5,100
New +$89.6K ﹤0.01% 2609

Other funds holding ETNB

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Russell Investments Group's ETNB Position: Q4 2025 in Review

Russell Investments Group sold out of 89bio (ETNB) in Q4 2025, closing a stake of 10,338 shares — an estimated $152K sold.

Russell Investments Group first reported a position in ETNB in Q2 2023 and held it in 6 quarters. The position peaked at $321K in Q3 2024. 2 funds tracked by Wall St. Rank hold ETNB as of Q4 2025.

  • Russell Investments Group reported no remaining 89bio position as of Q4 2025 after selling out during the quarter.
  • Russell Investments Group sold 10,338 89bio shares in Q4 2025, an estimated $152K.
  • Russell Investments Group first reported a position in 89bio in Q2 2023 and held it in 6 quarters.
  • Russell Investments Group's 89bio position peaked at $321K in Q3 2024.
  • 2 funds tracked by Wall St. Rank held 89bio as of Q4 2025.

Based on Russell Investments Group's 13F filing for Q4 2025, filed 17 Feb 2026.